TLTFF (Theralase Technologies) Shiller PE Ratio: (As of Aug. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TLTFF Theralase Technologies Inc TLTFF
45 GF Score
Price $0.13
GF Value $0.13
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Theralase Technologies Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Theralase Technologies  (OTCPK:TLTFF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Theralase Technologies Shiller PE Ratio Related Terms


Theralase Technologies Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Theralase Technologies's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theralase Technologies Shiller PE Ratio Chart

Theralase Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Theralase Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TLTFF vs ABT, SYK, MDT: Shiller PE Ratio Comparison

For the Medical Devices subindustry, Theralase Technologies's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Theralase Technologies Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Theralase Technologies's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Theralase Technologies's Shiller PE Ratio falls into.


TLTFF
45GF Score
Theralase Technologies Inc TLTFF
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Theralase Technologies Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Theralase Technologies's E10 for the quarter that ended in Mar. 2026 is calculated as:

For example, Theralase Technologies's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.003/132.2623*132.2623
=-0.003

Current CPI (Mar. 2026) = 132.2623.

Theralase Technologies Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201606 -0.008 102.002 -0.010
201609 -0.011 101.765 -0.014
201612 -0.006 101.449 -0.008
201703 -0.010 102.634 -0.013
201706 -0.008 103.029 -0.010
201709 -0.011 103.345 -0.014
201712 -0.007 103.345 -0.009
201803 -0.006 105.004 -0.008
201806 -0.008 105.557 -0.010
201809 -0.005 105.636 -0.006
201812 -0.004 105.399 -0.005
201903 -0.006 106.979 -0.007
201906 -0.008 107.690 -0.010
201909 -0.008 107.611 -0.010
201912 -0.016 107.769 -0.020
202003 -0.037 107.927 -0.045
202006 -0.006 108.401 -0.007
202009 -0.008 108.164 -0.010
202012 -0.005 108.559 -0.006
202103 -0.003 110.298 -0.004
202106 -0.005 111.720 -0.006
202109 -0.004 112.905 -0.005
202112 -0.005 113.774 -0.006
202203 -0.006 117.646 -0.007
202206 -0.005 120.806 -0.005
202209 -0.004 120.648 -0.004
202212 -0.003 120.964 -0.003
202303 -0.005 122.702 -0.005
202306 -0.004 124.203 -0.004
202309 -0.004 125.230 -0.004
202312 -0.004 125.072 -0.004
202403 -0.004 126.258 -0.004
202406 -0.004 127.522 -0.004
202409 -0.003 127.285 -0.003
202412 -0.003 127.364 -0.003
202503 -0.004 129.181 -0.004
202506 -0.003 129.892 -0.003
202509 -0.003 130.287 -0.003
202512 -0.001 130.366 -0.001
202603 -0.003 132.262 -0.003

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Theralase Technologies (TLTFF) Overvalued in 2026?

Based on GuruFocus' analysis, Theralase Technologies stock appears to be overvalued. The current stock price of $0.13 is trading 3.7% above its estimated GF Value™ of $0.13. GuruFocus considers Theralase Technologies to be Fairly Valued.

Key valuation signals for TLTFF:

  • Shiller PE Ratio:
  • GF Value™: $0.13 vs. price of $0.13 (3.7% above fair value)
  • GF Score™: 45/100 with 4 warning signs

No single metric tells the full story. See the TLTFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Theralase Technologies Business Description

Other Exchanges TTX:GermanyTLT:Canada
Address 41 Hollinger Road, Toronto, ON, CAN, M4B 3G4
Theralase Technologies Inc brings CLT to patients and personalized ACT to patients based on individual tissue characteristics. It is two separate reportable operating divisions; the Drug Division and the Device Division. The Drug Division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs), and activates them with proprietary and patent-pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The Device Division designs develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the Food and Drug Administration (FDA) for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions.
45GF Score

Get the complete analysis for TLTFF

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.13
Price
$0.13
GF Value